As Paul Hopper said in one of his interview (if you havent watch this, i highly recommend you to), most biotech trial fail at Phase 2 which is why biotech are generally underrated before Phase 2 result is released. I have never really hold or expose to biotech companies that went past Phase 2, any help with my questions above would be helpful.
As Paul Hopper said in one of his interview (if you havent watch...
-
- There are more pages in this discussion • 1,234 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $431.8M | |||
| Open | High | Low | Value | Volume |
| 5.9¢ | 5.9¢ | 5.6¢ | $1.037M | 17.94M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 1882949 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.9¢ | 399643 | 3 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |